Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Fall;16(3):238-42.

Pacing Without Wires: Leadless Cardiac Pacing

Michael L Bernard  1
Affiliations
Review

Pacing Without Wires: Leadless Cardiac Pacing

Michael L Bernard. Ochsner J. 2016 Fall.

Abstract

Background: Worldwide, more than 700,000 pacemakers are implanted annually with more than 250,000 implanted in the United States. Since the first fully transvenous pacemaker implantations in the early 1960s, great technologic advances have been made in pacing systems. However, the combination of subcutaneous pulse generators and transvenous pacing leads has remained constant for more than 50 years. Leadless pacing systems offer an alternative to traditional pacing systems by eliminating the need for permanent transvenous leads while providing therapy for patients with bradyarrhythmias.

Methods: We discuss the 2 leadless cardiac pacemakers (LCPs), the Nanostim Leadless Pacemaker and Micra Transcatheter Pacing System, and the 1 ultrasound-powered device, the WiCS-LV, that have been studied in humans. Currently LCPs are restricted to single-chamber pacing, specifically, ventricular pacing. Dual-chamber pacing and multichamber pacing with leadless systems have yet to be studied.

Results: LCPs represent the greatest advancement in bradycardia therapy since the first transvenous pacemaker implantation more than 50 years ago.

Conclusion: Initial studies of both the Nanostim and Micra LCPs show favorable efficacy and safety results compared to transvenous pacemakers. Pending US Food and Drug Administration approval, these devices will transform our ability to provide pacing for patients with bradyarrhythmias. Future developments may allow for completely leadless single-chamber and multichamber pacing, ushering in an era of pacing without wires.

Keywords: Bradycardia; cardiac pacing–artificial; pacemaker–artificial.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Nanostim Leadless Pacemaker. Nanostim and St. Jude Medical are trademarks of St. Jude Medical, Inc. or its related companies. Reproduced with permission of St. Jude Medical, © 2016. All rights reserved.
Figure 2.
Figure 2.
Nanostim Leadless Pacemaker delivery. Nanostim and St. Jude Medical are trademarks of St. Jude Medical, Inc. or its related companies. Reproduced with permission of St. Jude Medical, ©2016. All rights reserved.
Figure 3.
Figure 3.
Micra Transcatheter Pacing System. Reproduced with permission of Medtronic.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011. August; 34 8: 1013- 1027. doi: 10.1111/j.1540-8159.2011.03150.x. - DOI - PubMed
    1. Parsonnet V, Zucker IR, Gilbert L, Maxim ASA M. An intracardiac bipolar electrode for interim treatment of complete heart block. Am J Cardiol. 1962. August; 10: 261- 265. - PubMed
    1. Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012. May; 9 5: 728- 735. doi: 10.1016/j.hrthm.2011.12.014. - DOI - PubMed
    1. Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol. 2003. September 15; 92 6: 740- 741. - PubMed
    1. Reddy VY, Knops RE, Sperzel J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014. April 8; 129 14: 1466- 1471. doi: 10.1161/CIRCULATIONAHA.113.006987. - DOI - PubMed

LinkOut - more resources